바이오니아

064550KOSDAQ의료용품 및 기타 의약 관련제품 제조업

41.0 / 100

Reference Date: 2026-04-13

Financial Score11.5 / 40

News Sentiment12.5 / 25

Momentum7.0 / 20

Disclosure10.0 / 15

AI Analysis: PBR is significantly undervalued vs. peers but the high debt ratio poses financial risk. Declined 14.7% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

BioNia is a biopharmaceutical company specializing in developing solutions for disease diagnosis, treatment, and prevention based on core biotechnology, with key businesses in life science research products, molecular diagnostics, probiotics, and RNAi-based drug development. Over 33 years, it has accumulated advanced genetic technologies, supplying PCR equipment, molecular diagnostic kits, and expanding into new areas like synthetic biology bioprinting and RNA-based cosmetics.

Number of Employees

362people

Average Salary

52.4M KRW

Score Calculation Basis

Detailed Financial Score

PER

157.86Industry Average 19.890.0Point

7.9x industry avg (risky)

PBR

1.19Industry Average 1.625.5Point

Lower than industry avg (good)

ROE

0.75Industry Average -4.893.5Point

Well below industry avg

Debt Ratio

33.85Industry Average 8.880.0Point

3.8x industry avg (risky)

Trend 2023~20252.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲12.0% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼790.5% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -3.5% (improving, 3yr)

Detailed News Sentiment

5 totalPositive 0Neutral 3Negative 0Average Sentiment Score 50

Neutral
대전TP, 독일 프라운호퍼와 손잡고 글로벌 연구산업 공략
대전테크노파크가 독일 프라운호퍼연구소와 손잡고 지역 연구산업의 글로벌 영토 확장에 나섰습니다.
Neutral
과기정통부, 국산 장비 해외 판로 개척 지원
과학기술정보통신부가 국산 연구장비의 해외 판로 개척을 지원하기 위해 세계적인 연구장비 전시회에 한국관을 조성합니다.
Neutral
정부, 국산 연구장비 해외 진출 지원…3대 전시회 중심 판로 확대
과학기술정보통신부가 국산 연구장비의 해외 판로 개척을 지원하기 위해 3대 전시회 중심으로 한국관을 운영합니다.

Detailed Momentum

52-week position1.0Point

Near 52w low (6%, downtrend)

Current 10,440Won52-week high 17,55052-week low 9,950

1-month return1.0Point

1m -14.71% (falling)

Volume trend5.0Point

Volume flat

Detailed Disclosure

9 totalPositive 0Neutral 9Negative 0

Neutral[기재정정]정기주주총회결과2026-04-07
Neutral[기재정정]정기주주총회결과2026-04-02
Neutral[기재정정]정기주주총회결과2026-04-02
Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-31
Neutral정기주주총회결과2026-03-31